Zoladex
Brainstem Glioma
Children's Hospital Medical Center, CincinnatiPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Brainstem Glioma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(+)-VINCRISTINE Julie Krystal | Phase 2 | BB |
Valproic Acid Baylor College of Medicine | Phase 2 | B |
Carboplatin Julie Krystal | Phase 1/2 | CCC |
Irinotecan Julie Krystal | Phase 1/2 | CCC |
FULVESTRANT Children's Hospital Medical Center, Cincinnati | Phase 1 | CC |
View all 10 →
Same molecule, other indications
Zoladex is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →